PAPER Dobrogowska DH, Vorbrodt AW, Wegiel J, Wang KC, Shoji M, Mondadori C, Polatis G, Giovanni A, Wisniewski HM
SEARCH RESULTS
345052 RESULTS
PAPER Brodaty H, Ames D, Boundy KL, Hecker J, Snowdon J, Storey E, Yates MW
Pharmacological treatment of cognitive deficits in Alzheimer's disease.
Med J Aust. 2001 Sep 17;175(6):324-9. PubMed.PAPER Iritani S, Niizato K, Emson PC
Relationship of calbindin D28K-immunoreactive cells and neuropathological changes in the hippocampal formation of Alzheimer's disease.
Neuropathology. 2001 Sep;21(3):162-7. PubMed.PAPER Thorns V, Licastro F, Masliah E
Locally reduced levels of acidic FGF lead to decreased expression of 28-kda calbindin and contribute to the selective vulnerability of the neurons in the entorhinal cortex in Alzheimer's disease.
Neuropathology. 2001 Sep;21(3):203-11. PubMed.PAPER Pompei P, Severini R, Pediconi D, Angeletti M, Eleuteri A, Fattoretti P, Bertoni-Freddari C, Fioretti E
Regulation of preprotachykinin-A gene expression in an animal model of Alzheimer's disease.
J Histochem Cytochem. 2001 Nov;49(11):1469-70. PubMed.PAPER Ohnishi T, Matsuda H, Tabira T, Asada T, Uno M
Changes in brain morphology in Alzheimer disease and normal aging: is Alzheimer disease an exaggerated aging process?
AJNR Am J Neuroradiol. 2001 Oct;22(9):1680-5. PubMed.PAPER Gosche KM, Mortimer JA, Smith CD, Markesbery WR, Snowdon DA
An automated technique for measuring hippocampal volumes from MR imaging studies.
AJNR Am J Neuroradiol. 2001 Oct;22(9):1686-9. PubMed.PAPER Borenstein Graves A, Mortimer JA, Bowen JD, McCormick WC, McCurry SM, Schellenberg GD, Larson EB
Head circumference and incident Alzheimer's disease: modification by apolipoprotein E.
Neurology. 2001 Oct 23;57(8):1453-60. PubMed.PAPER Hashimoto M, Yasuda M, Tanimukai S, Matsui M, Hirono N, Kazui H, Mori E
Apolipoprotein E epsilon 4 and the pattern of regional brain atrophy in Alzheimer's disease.
Neurology. 2001 Oct 23;57(8):1461-6. PubMed.PAPER Adair JC, Knoefel JE, Morgan N
Controlled trial of N-acetylcysteine for patients with probable Alzheimer's disease.
Neurology. 2001 Oct 23;57(8):1515-7. PubMed.PAPER Kato T
The other, forgotten genome: mitochondrial DNA and mental disorders.
Mol Psychiatry. 2001 Nov;6(6):625-33. PubMed.PAPER Clarke NJ, Crow FW, Younkin S, Naylor S
Analysis of in vivo-derived amyloid-beta polypeptides by on-line two-dimensional chromatography-mass spectrometry.
Anal Biochem. 2001 Nov 1;298(1):32-9. PubMed.PAPER Heo HJ, Cho HY, Hong B, Kim HK, Kim EK, Kim BG, Shin DH
Protective effect of 4',5-dihydroxy-3',6,7-trimethoxyflavone from Artemisia asiatica against Abeta-induced oxidative stress in PC12 cells.
Amyloid. 2001 Sep;8(3):194-201. PubMed.PAPER Dalle-Donne I, Rossi R, Giustarini D, Gagliano N, Lusini L, Milzani A, Di Simplicio P, Colombo R
Actin carbonylation: from a simple marker of protein oxidation to relevant signs of severe functional impairment.
Free Radic Biol Med. 2001 Nov 1;31(9):1075-83. PubMed.PAPER Ruiz-León Y, Pascual A
Brain-derived neurotrophic factor stimulates beta-amyloid gene promoter activity by a Ras-dependent/AP-1-independent mechanism in SH-SY5Y neuroblastoma cells.
J Neurochem. 2001 Oct;79(2):278-85. PubMed.Current Filters
No filters selected